You are not alone, lots of armchair analysts here with incredibly unrealistic expectations. I'm bullish but very realistic.
You guys need to come back to earth a bit. It will go up if things progress as they have. We need more PT's , my fear is that this pulls a SRPT on us. Vids are great but they don't always equate to FDA approval or having to deal with further studies . If we do see continued success and price goes up with each PT NVIV gets bought and bought quickly. Now way NVIV takes this to market on their own. It's nice they have a GLTA strategy listed in their investor presentation but we all know a big boy will try and #$%$ this co up.
The amount of diseases they can go after with the Lenti platform is pretty incredible. They've got to be getting close to announcing new piepeline targets soon. Not to mention their CAR-T program
No other explanation for the quackery here.